Bhuyan et al., 1983 - Google Patents
Cell cycle effects of CC-1065Bhuyan et al., 1983
- Document ID
- 13931269765687747289
- Author
- Bhuyan B
- Crampton S
- Adams E
- Publication year
- Publication venue
- Cancer research
External Links
Snippet
CC-1065 is the most potent antitumor agent tested in our laboratory. It is lethal to B16 and CHO cells and to a variety of human tumors in the clonogenic assay at 1 ng/ml and is effective against L1210 leukemia and B16 melanoma in vivo at 1 to 50 µg/kg. CC-1065 …
- 230000000694 effects 0 title description 14
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Otten et al. | Regulation of cell growth by cyclic adenosine 3′, 5′-monophosphate: Effect of cell density and agents which alter cell growth on cyclic adenosine 3′, 5′-monophosphate levels in fibroblasts | |
Tupper et al. | Potassium transport and content during G1 and S phase following serum stimulation of 3T3 cells | |
Gurley et al. | The metabolism of histone fractions: I. Synthesis of histone fractions during the life cycle of mammalian cells | |
Tobey | Production and characterization of mammalian cells reversibly arrested in G1 by growth in isoleucine-deficient medium | |
Wang et al. | Aerobic glycolysis during lymphocyte proliferation | |
Sehgal et al. | 5, 6-Dichloro-1-β-D-ribofuranosylbenzimidazole inhibits initiation of nuclear heterogeneous RNA chains in HeLa cells | |
van Wijk et al. | Effects of derivatives of cyclic 3′, 5′-adenosine monophosphate on the growth, morphology, and gene expression of hepatoma cells in culture | |
Sell et al. | Relationship of the biosynthesis of α‐fetoprotein, albumin, hemopexin, and haptoglobin to the growth state of fetal rat hepatocyte cultures | |
Holliday et al. | A role for carnosine in cellular maintenance | |
Latham et al. | Distribution of mRNA in the cytoplasmic polyribosomes of the HeLa cell | |
Clausen et al. | Separation of mouse epidermal basal and differentiating cells for microflow fluorometric measurements: a methodologic study | |
Sawicki et al. | On the differential cytotoxicity of actinomycin D | |
Coyle et al. | Cell killing and the accumulation of breaks in the DNA of HEp-2 cells incubated in the presence of hydroxyurea | |
Butcher et al. | Induction of tyrosine aminotransferase by dibutyryl cyclic-AMP employing hepatoma cells in tissue culture | |
Bhuyan et al. | Cell cycle effects of CC-1065 | |
Jenkinson et al. | Temporal dissociation of late events in Bacillus subtilis sporulation from expression of genes that determine them | |
Affolter et al. | Regulation of histone and βA-globin gene expression during differentiation of chicken erythroid cells | |
Miki et al. | Inhibition of intercellular communication by nickel (II): antagonistic effect of magnesium | |
Okuda et al. | Effects of serum deprivation on the initiation of DNA synthesis in the second generation in rat 3Y1 cells | |
Lough et al. | Differential sensitivity to 5-bromodeoxyuridine during the S phase of synchronized myogenic cells | |
Jones et al. | The effect of 1-β-D-arabinofuranosylcytosine on cell viability, DNA synthesis, and chromatid breakage in synchronized hamster fibrosarcoma cells | |
Bhuyan et al. | Lethality of nogalamycin, nogalamycin analogs, and Adriamycin to cells in different cell cycle phases | |
Wharton et al. | Inhibition of BALB/c‐3T3 cells in late G1: Commitment to DNA synthesis controlled by somatomedin C | |
Mager et al. | The role of heme in the regulation of the late program of Friend cell erythroid differentiation | |
Loffler et al. | Further characterization of the growth inhibitory effect of rotenone on in vitro cultured Ehrlich ascites tumour cells |